/Companies

Bright Biotech

3 known investors

Find your way into Bright Biotech

Sign up to find every way you can get introduced to Bright Biotech

  • Your email: who you already know at Bright Biotech, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bright Biotech team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Bright Biotech produces recombinant proteins, including growth factors, by expressing them in plant chloroplasts. Its proteins are aimed at cell culture and regenerative medicine applications.

Investors · 3

Companies House · registry record

View on Companies House ↗
Registered name
BRIGHT BIOTECH LIMITED
Company number
12253910
Status
Active
Company type
Private limited company
Incorporated
10 Oct 2019
Registered office
Rutherford House Unit 16 Pencroft Way, Manchester Science Park, Manchester, M15 6SZ
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement
last made up to 20 Sept 2025 · next due 4 Oct 2026

Current officers · 4

  • Mohammad Farid Khan — secretary, appointed 10 Oct 2019
  • Mohammad El Hajj — director, appointed 10 Oct 2019
  • Adrian Friederich — director, appointed 30 Apr 2025
  • Mohammad Farid Khan — director, appointed 3 Oct 2022

Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Bright Biotech do?
Bright Biotech produces recombinant proteins, including growth factors, by expressing them in plant chloroplasts. Its proteins are aimed at cell culture and regenerative medicine applications.
Who are Bright Biotech's investors?
Bright Biotech's investors include Big Idea Ventures, FoodLabs, CPT Capital.